This information changes to reflect current statistics. Reporting by many agencies is on a periodic basis rather than every year:
The current rate of diagnosis of all Diabetes is one new case every 30 seconds, or 2880 new Diabetes cases every day globally.
One person dies every 7 seconds from Diabetes related causes globally.
29 million Americans have Diabetes
1.9 million are Type 1
Type 1 Diabetes comprises 5 -10% of the total diabetes population making it a rare disease.
Type 1 Diabetes comprises about 27 million of the total cases globally.
Type I is increasing at the rate of 23% per year in the U.S.
Type II is increasing at the rate of 39% in the U.S.
Diabetes has a current world statistic of 412 million people, (Type 1 and Type 2) diagnosed.
It is expected there will be in excess of 552 million people diagnosed globally by 2030, almost doubling the current cases being diagnosed. 5.5 million of them will be Type 1.
Diagnosis of all diabetes is now crossing age, weight, ethnic and socio-economic boundaries once thought to be static.
The age of diagnosis is decreasing over time and is being diagnosed among smaller children and babies in increasing numbers for both types.
Of children being diagnosed with Type 1 Diabetes, 96% of children under age 3 and 67% under age 5 will suffer death or permanent lifetime handicap equal to the severity of Diabetic Keto-acidosis at the time of diagnosis.
Finland has the highest diagnosis of Type 1 Diabetes globally.
Colorado has the highest rate of diagnosis of Type 1 Diabetes in the United States, and is closely followed by Minnesota and Pennsylvania. Reporting by providers and states may not accurately reveal the actual numbers and this may be under-reported.
At the time of it's release in 1927 insulin was priced at less than $1.49 US a vial.
Pricing has increased to approximately $300-$600 US a vial. Average usage being 2-4 vials per month.
Testing strips necessary for self dosing of insulin average a cost of $2 US per strip for 8-14 strips a day ($16 - $24 US daily).
Insurance coverage for these lifesaving supplies is lacking for many or grossly inadequate for the larger community in the U.S.
(Statistics courtesy of CDC, IDF, and NIH.)